Validation of the RSClin risk calculator in the National Cancer Data Base.

Augustin G L VannierAsim DhunganaFangyuan ZhaoNan ChenSarah ShubeckOlwen M HahnRita NandaNora T JaskowiakGini F FlemingOlufunmilayo I OlopadeAlexander T PearsonDezheng HuoFrederick M Howard

Published in: Cancer (2023)

RSClin may identify high-risk patients who benefit from treatment intensification more accurately than OncotypeDx, and further prospective study is needed.

Keyphrases

electronic health record
big data
machine learning
combination therapy
replacement therapy